Tranylcypromine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Black Box Warning
|
TITLE
See full prescribing information for complete Boxed Warning.
Condition Name: (Content)
|
Overview
Tranylcypromine is a MAO that is FDA approved for the {{{indicationType}}} of major depressive disorder. There is a Black Box Warning for this drug as shown here. Common adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
- Major depressive disorder
- 30 mg/day PO, after 2 weeks, may increase by 10 mg/day every 1-3 weeks to a :*Maximum dose of 60 mg/day
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information about Off-Label Guideline-Supported Use of Tranylcypromine in adult patients.
Non–Guideline-Supported Use
There is limited information about Off-Label Non–Guideline-Supported Use of Tranylcypromine in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Safety and effectiveness in children have not been established
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information about Off-Label Guideline-Supported Use of Tranylcypromine in pediatric patients.
Non–Guideline-Supported Use
There is limited information about Off-Label Non–Guideline-Supported Use of Tranylcypromine in pediatric patients.
Contraindications
There is limited information regarding Tranylcypromine Contraindications in the drug label.
Warnings
|
TITLE
See full prescribing information for complete Boxed Warning.
Condition Name: (Content)
|
There is limited information regarding Tranylcypromine Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Tranylcypromine Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Tranylcypromine Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Tranylcypromine Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Tranylcypromine in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Tranylcypromine in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Tranylcypromine during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Tranylcypromine in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Tranylcypromine in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Tranylcypromine in geriatric settings.
Gender
There is no FDA guidance on the use of Tranylcypromine with respect to specific gender populations.
Race
There is no FDA guidance on the use of Tranylcypromine with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Tranylcypromine in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Tranylcypromine in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Tranylcypromine in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Tranylcypromine in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Tranylcypromine Administration in the drug label.
Monitoring
There is limited information regarding Tranylcypromine Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Tranylcypromine and IV administrations.
Overdosage
There is limited information regarding Tranylcypromine overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
Mechanism of Action
There is limited information regarding Tranylcypromine Mechanism of Action in the drug label.
Structure
There is limited information regarding Tranylcypromine Structure in the drug label.
Pharmacodynamics
There is limited information regarding Tranylcypromine Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Tranylcypromine Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Tranylcypromine Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Tranylcypromine Clinical Studies in the drug label.
How Supplied
There is limited information regarding Tranylcypromine How Supplied in the drug label.
Storage
There is limited information regarding Tranylcypromine Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Tranylcypromine |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Tranylcypromine |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Tranylcypromine Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Tranylcypromine interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Tranylcypromine Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Tranylcypromine Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ 1.0 1.1 1.2 Williams, David A. (2007). = R0W1ErpsQpkC&pg = PA590 "Antidepressants" Check
|chapterurl=value (help). In Foye, William O.; Lemke, Thomas L.; Williams, David A. Foye's Principles of Medicinal Chemistry. Hagerstwon, MD: Lippincott Williams & Wilkins. pp. 590–1. ISBN 0-7817-6879-9.